期刊
BIOMARKERS IN MEDICINE
卷 14, 期 6, 页码 421-432出版社
FUTURE MEDICINE LTD
DOI: 10.2217/bmm-2019-0357
关键词
COX-2; gastric cancer; metastasis; mTOR; prognosis
资金
- National Natural Science Foundation of China [81773944]
- Young Medicine Focus Talent Foundation of Jiangsu Province [QNRC2016206]
- Postgraduate Research by Practice Innovation Program of Jiangsu Province [KYCX18 2382]
- Natural Science Foundation of Jiangsu Province [BK20191149]
- China Postdoctoral Science Foundation [2018M642346]
- Wuxi City Health Planning Commission project [MS201815]
Aim: Gastric cancer (GC) is one of the most common malignant tumors in the world. It is important to find accurate and reliable biomarkers in order to decrease whole morbidity and mortality. Results: We examined the expression of COX-2 and mTOR on GC tissue microarrays by immunohistochemistry. Multi-variate COX regression analysis showed that the expression of COX-2 or mTOR was an independent factor in the prognosis of GC patients. In addition, COX-2 and mTOR had the potentially synergistic effect on predicting the prognosis of GC. Conclusion: The combined expression of COX-2 and mTOR could serve as efficient prognostic indicators and COX-2 could suppress GC metastasis via regulating mTOR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据